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TCT-39
Comprehensive intravascular Ultrasound Assessment of Stent Area and Its
Impact on Restenosis and Adverse Cardiac Events in 403 Patients with
Unprotected Left Main Disease
Soo-Jin Kang1, Jong-Young Lee1, Jung-Min Ahn1, Haegeun Song1, Won-Jang Kim1,
Duk-Woo Park1, Seung-Whan Lee1, Young-Hak Kim1, Cheol Whan Lee1, Gary S
Mintz2, Seong-Wook Park1, Seung-Jung Park1
1Asan Medical Center, Seoul, Republic of Korea; 2Cardiovascular Research
Foundation, New York, NY
Background: We assessed the optimal intravascular ultrasound (IVUS) stent area to
prevent angiographic in-stent restenosis (ISR) after sirolimus-eluting stent implantation
for unprotected left main coronary artery (LM) disease.
Methods: A total of 403 patients treated with single- or two-stent strategies (crushing
and T-stent) had immediate post-stenting IVUS and 9-month follow-up angiography.
Post-stenting minimal stent area (MSA) was measured in each of 4 segments: ostial
left anterior descending (LAD), ostial left circumflex (LCX) polygon of confluence
(POC, confluence zone of LAD and LCX), and proximal LM above the POC.
Results: Overall, 46 (11.4%) showed angiographic restenosis at 9 months: 3/67 (4.5%)
non-bifurcation lesions treated with a single-stent, 14/222 (6.3%) bifurcation lesions
treated with single-stent cross-over, and 29/114 (25.4%) of bifurcation lesions treated
with two stents. The MSA cut-offs that best predicted ISR on a segmental basis were
5.0mm2 (ostial LCX ISR), 6.3mm2 (ostial LAD ISR), 7.2mm2 (ISR within the POC),
and 8.2mm2 (ISR within the LM above the POC). Using these criteria, 133 (33.8%)
had underexpansion of at least one segment. Angiographic ISR (at any location) was
more frequent in lesions with underexpansion of at least one segment vs. lesions with
no underexpansion (24.1% vs. 5.4%, p<0.001). Two-year MACE-free survival rate
was significantly lower in patients with underexpansion of at least one segment vs.
lesions with no underexpansion (89±3% vs. 98±1%, log-rank p<0.001); and post-
stenting underexpansion was an independent predictor for major adverse cardiac events
(adjusted HR=5.56, 95% CI=1.99–15.49, p=0.001).
Conclusion: With these criteria, IVUS optimization during LMCA stenting procedures
may improve clinical outcomes.
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Strut thickness and type of metal alloy of bare metal stents and frequency of in-
stent-restenosis: Data from the Swedish Angiography and Angioplasty Registry
(SCAAR)
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Background: In-stent-restenosis is influenced by patient-, lesion- and procedural
characteristics. Strut thickness is thought to be a determinant of in-stent-restenosis
where landmark studies showed that thinner struts were associated with lower
restenosis rates. These studies used stents with extreme strut thickness (50 μm and 140
μm). We used the SCAAR database to investigate the question whether strut thickness
and type of metal alloy influences restenosis rates in currently used BMS.
Methods: 75 448 BMS with strut thickness between 65 μm and 100 μm were included
between May 1, 2005 and April 6, 2010. The follow-up ended Oktober 6, 2010 with a
minimum follow-up of 6 months and a maximum follow-up of 5 years and 5 months
(mean follow-up 1080 days ± 523). The data were analyzed with regard to stent strut
thickness and metal alloy composition (second generation L605 cobalt-chromium
versus first generation 316L). The analysis was adjusted for differences in clinical and
procedural baseline characteristics.
Results: The figure shows the adjusted frequency of restenosis depending on strut
thickness. The relative risk was 0.995 for thicker struts (95% confidence interval 0.990-
0.999), p=0.017. Type of metal alloy (605 versus 316) did not influence restenosis rates
with a relative risk of 1.009 (95% confidence interval 0.926-1.100), p=0.833.
Frequency of in-stent restenosis and strut thickness (μm)
Conclusion: The old dogma that thinner stent struts are associated with lower
restenosis rates may no longer be true with modern BMS. Type of metal alloy did not
influence restenosis rate in this large real world registry.
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Impact of final kissing balloon on outcome after unprotected left main stenting
Klaus Tiroch1, 2, Julinda Mehilli2, Melchior Seyfarth1, Adnan Kastrati2
1Herzzentrum, Wuppertal, Germany; 2Herzzentrum, Munich, Germany
Background: The stenting technique for unprotected left main disease (uLMCA) using
drug-eluting stents (DES) is under debate.
Methods: This analysis is based on a randomized study. 607 patients with symptomatic
uLMCA disease were treated with DES (302 with Taxus and 305 with Cypher). We
evaluated the benefit of final kissing balloon dilatation depending on the bifurcation
type, number of stents and stenting technique on the angiographic restenosis rate (ISR),
the need of target lesion revascularisation (TLR), as well as the change of the
sidebranch diameter stenosis (Δ%DS) at 6 months.
Results: 520 (86%) patients had distal bifurcation involvement and 235 (39%) had a
true bifurcation lesion (TBL, Medina 1,1,1). The ISR rate was 18% and the TLR rate
10% with low 30-day mortality (1%). Kissing was performed more often with multiple-
stenting (72% vs. 15%, p<0.001) and for culotte vs. T-stenting (86% vs. 41%, p<0.001),
leading to improvement of a suboptimal acute result (p<0.001). With provisional
single-stenting, final kissing did not influence the ISR (12% vs. 10%, P=0.85) or TLR
rates (8% vs. 8%, P=0.84), with low Δ%DS (4%), not influenced by kissing (5% vs.
4%, P=0.53). Interestingly, after achieving an optimal angiographic result with multiple
stenting, final kissing had no additional benefit on the ISR (30% vs. 33%, P=0.84) or
TLR rates (14% vs. 12%, P=0.87), with low Δ%DS (16%), not influenced by kissing
(17% vs. 14%, P=0.32).
Conclusion: Provisional stenting is the preferred stenting technique (if SB <50%
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